Dysport
Dysport is a major botulinum toxin type A brand associated with Ipsen, with Galderma holding aesthetic commercialization rights in licensed territories including the United States. Its nonproprietary name is abobotulinumtoxinA.
Dysport often appears with larger numeric unit amounts than some other type A products. Those numbers are not a conversion scale. They reflect product-specific potency testing, labeling, and clinical-study context rather than a universal botulinum toxin unit.
Product Identity
Section titled “Product Identity”| Field | Reference point |
|---|---|
| Brand | Dysport |
| Nonproprietary name | AbobotulinumtoxinA |
| Toxin type | Botulinum toxin type A |
| Manufacturer / company context | Ipsen product origin; Galderma aesthetic commercialization in licensed territories |
| Comparison anchors | Botox, Xeomin, Daxxify, Letybo, Jeuveau |
Label Context
Section titled “Label Context”U.S. Dysport interpretation should stay anchored to the current prescribing information. Therapeutic and aesthetic discussions can overlap in everyday use, but approval language, dose ranges, patient populations, and warnings are label-specific.
Regional availability also matters. A Dysport claim supported in one country or product-information document should not be copied into another market without checking the local label.
Market Interpretation
Section titled “Market Interpretation”Dysport is a durable comparison point because it sits beside Botox and Xeomin in many professional and consumer discussions. Its value in the knowledge graph is not that it is directly interchangeable with those brands, but that it helps readers see how type A products can share broad biology while differing in formulation, labeling, unit language, and market position.
Graph Connections
Section titled “Graph Connections”Ipsen provides the product-origin and therapeutic-franchise context behind Dysport. Galderma explains the aesthetic commercialization relationship in licensed markets. Botox and Xeomin are the closest established type A comparison anchors, while botulinum toxin explains why the shared category does not create unit equivalence.